{
    "thread": {
        "uuid": "bc6130ca594cc236369c8bfb6da1bf37961eb4b5",
        "url": "https://www.cmoney.tw/notes/note-detail.aspx?nid=938814",
        "site_full": "www.cmoney.tw",
        "site": "cmoney.tw",
        "site_section": "http://www.cmoney.tw/notes/?bid=22814",
        "site_categories": [
            "investing",
            "financial_news",
            "finance",
            "stocks"
        ],
        "section_title": "投資網誌 -閱讀是最好的投資",
        "site_title": "理財寶 - 投資好軟體，我只推薦理財寶",
        "title": "Verastem Oncology 獲美FDA批准啟動新癌症療法臨床試驗！",
        "title_full": "Verastem Oncology 獲美FDA批准啟動新癌症療法臨床試驗！",
        "published": "2025-04-24T00:36:00.000+03:00",
        "replies_count": 0,
        "participants_count": 1,
        "site_type": "news",
        "country": "TW",
        "main_image": "https://image.cmoney.tw/attachment/blog/1745424000/233d7260-e944-4510-879d-83a269465040.jpg",
        "performance_score": 0,
        "domain_rank": 140092,
        "domain_rank_updated": "2025-04-22T00:00:00.000+03:00",
        "licensing_agency": [],
        "social": {
            "facebook": {
                "likes": 0,
                "comments": 0,
                "shares": 0
            },
            "vk": {
                "shares": 0
            }
        }
    },
    "uuid": "bc6130ca594cc236369c8bfb6da1bf37961eb4b5",
    "url": "https://www.cmoney.tw/notes/note-detail.aspx?nid=938814",
    "ord_in_thread": 0,
    "author": "CMoney AI 研究員",
    "published": "2025-04-24T00:36:00.000+03:00",
    "title": "Verastem Oncology 獲美FDA批准啟動新癌症療法臨床試驗！",
    "text": "Verastem Oncology 宣佈，其口服KRAS G12D抑制劑VS-7375已獲得美國FDA的批准，將展開新的臨床試驗。\n在抗癌研究領域，Verastem Oncology 今日傳來令人振奮的訊息：該公司宣佈其口服KRAS G12D抑制劑VS-7375已獲得美國食品藥品監督管理局（FDA）的批准，可進行臨床試驗。此類治療針對特定基因突變，旨在為患者提供更有效的治療選擇。\nKRAS G12D是腫瘤中常見的突變之一，與多種癌症的發生密切相關，包括胰臟癌和結腸癌。根據統計，約有13%至25%的癌症患者攜帶這一突變，顯示出市場需求的龐大潛力。VS-7375作為一種靶向治療，有望改善這些患者的預後。\n此外，Verastem表示，該藥物的臨床試驗將評估其安全性及有效性，並期待能夠取得突破性的成果。然而，也有專家質疑，儘管靶向療法前景廣闊，但仍需克服耐藥性等挑戰。未來，若VS-7375能成功上市，將可能改寫許多患者的治療歷史。\n總體而言，此次FDA的批准標誌著癌症治療的一個重要里程碑，Verastem Oncology正全力以赴，希望能早日為患者帶來希望。\n點擊下方連結，開啟「美股K線APP」，獲得更多美股即時資訊喔！\n https://www.cmoney.tw/r/56/id7ogv\n免責宣言\n本網站所提供資訊僅供參考，並無任何推介買賣之意，投資人應自行承擔交易風險。\n文章相關股票",
    "highlightText": "",
    "highlightTitle": "",
    "highlightThreadTitle": "",
    "language": "chinese",
    "sentiment": "positive",
    "categories": [
        "Health",
        "Science and Technology",
        "Economy, Business and Finance"
    ],
    "topics": [
        "Health->health treatment and procedure",
        "Health->health organisation",
        "Health->cancer",
        "Science and Technology->scientific innovation",
        "Science and Technology->medical research",
        "Science and Technology->biotechnology",
        "Economy, Business and Finance->financial service",
        "Economy, Business and Finance->business reporting and performance",
        "Economy, Business and Finance->healthcare industry"
    ],
    "ai_allow": true,
    "has_canonical": false,
    "breaking": false,
    "webz_reporter": false,
    "external_links": [],
    "entities": {
        "persons": [],
        "locations": [],
        "organizations": []
    },
    "syndication": {
        "syndicated": null,
        "syndicate_id": null,
        "first_syndicated": false
    },
    "trust": {
        "categories": [],
        "bias": null,
        "source": {
            "type": null,
            "city": null,
            "state": null,
            "country": null,
            "domain_type": null,
            "agency": null,
            "organization_name": null
        }
    },
    "rating": null,
    "crawled": "2025-04-24T00:47:14.738+03:00",
    "updated": "2025-04-24T00:47:14.738+03:00"
}